A detailed history of Squarepoint Ops LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 74,993 shares of RPTX stock, worth $212,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,993
Previous 142,974 47.55%
Holding current value
$212,980
Previous $471,000 45.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.75 - $3.99 $186,947 - $271,244
-67,981 Reduced 47.55%
74,993 $257,000
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $350,066 - $544,805
115,916 Added 428.4%
142,974 $471,000
Q1 2024

May 15, 2024

SELL
$4.53 - $8.41 $124,253 - $230,677
-27,429 Reduced 50.34%
27,058 $127,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $175,448 - $642,401
54,487 New
54,487 $397,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $119M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.